National Cancer Institute
Found 771 results for your search:
Total relevant funding to Brain for this search:
$216,979,499
Fiscal Year FY 2017
Cancer Type [Brain]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 771 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(9) Biophysical Description of Age and Dose Dependent Changes to Dendritic Morphology that Impact Cognition following Radiation Cancer Therapy 5R01CA208526-02 $472,047 $472,047 CUCINOTTA, FRANCIS UNIVERSITY OF NEVADA LAS VEGAS
2
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma 5R01CA190121-05 $362,088 $362,088 VERHAAK, ROELAND JACKSON LABORATORY
3
(PQ 9) Synaptic basis of deficits in attention and executive function following cranial radiation 5R01CA208535-02 $451,564 $451,564 GROSSHANS, DAVID UNIVERSITY OF TX MD ANDERSON CAN CTR
4
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche 1R01CA216054-01 $324,411 $324,411 HAYDEN, MELANIE STANFORD UNIVERSITY
5
(PQ1) Molecular circuit of multi-ciliogenesis regulates choroid plexus differentiation and tumor development 1R01CA220551-01 $383,749 $383,749 ZHAO, HAOTIAN SANFORD RESEARCH/USD
6
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal 1R01CA219667-01 $554,770 $554,770 DUMAN, JOSEPH BAYLOR COLLEGE OF MEDICINE
7
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu 5R01CA185039-04 $373,436 $373,436 JAN, LILY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
8
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors 5R01CA194470-03 $446,627 $147,387 JANES, KEVIN UNIVERSITY OF VIRGINIA
9
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data 5R01CA185486-04 $517,690 $258,845 RABADAN, RAUL COLUMBIA UNIVERSITY HEALTH SCIENCES
10
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw 5R01CA185137-04 $882,372 $882,372 CHAREST, ALAIN BETH ISRAEL DEACONESS MEDICAL CENTER
11
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction 5R01CA185402-04 $318,923 $318,923 LI, XIONAN BAYLOR COLLEGE OF MEDICINE
12
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma 5R01CA184320-04 $738,276 $738,276 SARKARIA, JANN MAYO CLINIC ROCHESTER
13
0021.0001 CG 425 METAVIVOR 261200800001E $319,219,481 $365,891 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
14
2D MR Correlational Spectroscopy Platform for Molecular and Genetic Characterizations of Glioma 1R01CA203388-01A1 $427,689 $427,689 MAO, HUI EMORY UNIVERSITY
15
4-Channel Multimodal Ultrathin-Flexible SFE for cancer diagnosis and therapy 1R43CA211086-01A1 $300,000 $300,000 MCMORROW, GERALD VERAVANTI, INC.
16
5-hydroxymethylcytosine in human cancer 5R01CA160965-06 $394,250 $197,125 PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE
17
A CEST-MRI Reporter Gene for Image Guided Oncolytic Virotherapy 5R01CA203873-02 $406,309 $406,309 FARRAR, CHRISTIAN MASSACHUSETTS GENERAL HOSPITAL
18
A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy 5F31CA210535-02 $32,154 $32,154 RICCIONE, KATHERINE DUKE UNIVERSITY
19
A clone's genomic stability as biomarker of its DNA-damage resilience 1K99CA215256-01 $166,644 $166,644 ANDOR, NOEMI STANFORD UNIVERSITY
20
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers 5R33CA202900-02 $412,553 $412,553 BREUNIG, JOSHUA CEDARS-SINAI MEDICAL CENTER
21
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling 5R01CA181231-02 $362,569 $181,285 REITER, JEREMY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
22
A Mechanistic Understanding of Neuronal Activity Promotion of High-Grade Glioma Growth through Activity-Regulated Secretion of Neuroligin-3 5F31CA200273-03 $44,044 $44,044 VENKATESH, HUMSA STANFORD UNIVERSITY
23
A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy 1R21CA205564-01A1 $205,187 $205,187 CHIN, FREDERICK STANFORD UNIVERSITY
24
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors 1R01CA217956-01 $662,909 $662,909 BRADY-KALNAY, SUSANN CASE WESTERN RESERVE UNIVERSITY
25
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma. 1R01CA217179-01 $566,814 $566,814 MARKERT, JAMES UNIVERSITY OF ALABAMA AT BIRMINGHAM
26
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas 5R01CA198076-03 $1 $1 PORTNOW, JANA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
27
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors 5K07CA178100-05 $129,957 $129,957 HOCKING, MATTHEW CHILDREN'S HOSP OF PHILADELPHIA
28
A Unique Class of Reductively Activated Oncology Drugs 1R01CA208669-01A1 $718,986 $359,493 BOGER, DALE SCRIPPS RESEARCH INSTITUTE
29
A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases 1R21CA214299-01 $240,785 $60,196 SLATER, JOHN UNIVERSITY OF DELAWARE
30
AARP prospective study of diet and cancer ZIA CP010196-03152 $703,174 $35,159 Sinha, Rashmi DCEG (NCI)
31
Abramson Cancer Center Support Grant 3P30CA016520-41S1 $125,000 $2,500 DANG, CHI UNIVERSITY OF PENNSYLVANIA
32
Abramson Cancer Center Support Grant 3P30CA016520-41S2 $62,491 $1,250 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
33
Abramson Cancer Center Support Grant 5P30CA016520-41 $7,810,244 $156,205 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
34
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging 5R01CA166171-05 $480,667 $480,667 ZHOU, JINYUAN JOHNS HOPKINS UNIVERSITY
35
Adaptive resistance to HIF1a inhibition in hypoxia 5R01CA207377-02 $352,147 $116,209 QIAN, ZHENG DAVID OREGON HEALTH & SCIENCE UNIVERSITY
36
Adult Brain Tumor Consortium (ABTC) 5UM1CA137443-08 $1,998,892 $1,998,892 GROSSMAN, STUART JOHNS HOPKINS UNIVERSITY
37
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology 5R33CA206949-02 $475,865 $237,933 SPICER, TIMOTHY SCRIPPS FLORIDA
38
Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu 1R03CA212800-01 $77,750 $77,750 HANKINSON, TODD UNIVERSITY OF COLORADO DENVER
39
AIDS Malignancy Consortium (AMC) 5UM1CA121947-11 $22,965,613 $5,741,403 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
40
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-04S1 $2,088,480 $52,212 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
41
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-04 $11,145,123 $278,628 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
42
An 18F PET/NIRF Smart Probe for Identifying, Grading, and Visualizing Astrocytic Gliomas 1F32CA213620-01 $57,066 $57,066 HETTIE, KENNETH STANFORD UNIVERSITY
43
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer 5R01CA169345-05 $322,663 $322,663 WALDMAN, TODD GEORGETOWN UNIVERSITY
44
Anatomic Pathology Residency Program ZIE BC 011384 $1,094,457 $98,501 Barr, Frederic CCR (NCI)
45
Angiogenesis-targeting therapy for glioblastoma 3R01CA129371-10S1 $251,370 $251,370 BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL
46
Angiogenesis-targeting therapy for glioblastoma 5R01CA129371-10 $592,913 $592,913 BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL
47
Apoptotic Proteins as Molecular Modulators of Stem Cell Fate 5R00CA178190-05 $249,000 $249,000 GAMA, VIVIAN VANDERBILT UNIVERSITY
48
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy 1R33CA225328-01 $1,540,837 $1,540,837 LI, QIJING DUKE UNIVERSITY
49
Area B: Precise DCE-MRI Assessment of Brain Tumors 1R33CA225400-01 $1,561,994 $1,561,994 NAYAK, KRISHNA UNIVERSITY OF SOUTHERN CALIFORNIA
50
Asymmetric cell division drives therapeutic resistance and self-renewal in glioblastoma 1R03CA215939-01 $79,250 $79,250 HITOMI, MASAHIRO CLEVELAND CLINIC LERNER COM-CWRU
Total relevant funding to Brain for this search: $216,979,499
Showing 1 - 50 of 771 results
Go to top